Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Melanoma | 1 | 2023 | 110 | 0.720 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 178 | 0.690 |
Why?
|
| Opioid-Related Disorders | 2 | 2023 | 195 | 0.310 |
Why?
|
| Vaccination | 2 | 2025 | 355 | 0.240 |
Why?
|
| Tennessee | 4 | 2025 | 93 | 0.210 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2025 | 117 | 0.210 |
Why?
|
| Particulate Matter | 1 | 2025 | 83 | 0.210 |
Why?
|
| Oral Health | 1 | 2025 | 87 | 0.210 |
Why?
|
| DNA, Mitochondrial | 1 | 2025 | 191 | 0.210 |
Why?
|
| Medically Underserved Area | 1 | 2025 | 120 | 0.210 |
Why?
|
| Air Pollutants | 1 | 2025 | 130 | 0.200 |
Why?
|
| Buprenorphine | 1 | 2023 | 51 | 0.200 |
Why?
|
| Nutrition Therapy | 1 | 2022 | 10 | 0.190 |
Why?
|
| Fimbriae, Bacterial | 1 | 2023 | 30 | 0.190 |
Why?
|
| SEER Program | 1 | 2023 | 164 | 0.190 |
Why?
|
| Attitude of Health Personnel | 1 | 2025 | 231 | 0.190 |
Why?
|
| Environmental Exposure | 1 | 2025 | 256 | 0.190 |
Why?
|
| Papillomavirus Vaccines | 1 | 2025 | 174 | 0.180 |
Why?
|
| Humans | 17 | 2025 | 43102 | 0.180 |
Why?
|
| Skin | 1 | 2023 | 187 | 0.180 |
Why?
|
| Health Personnel | 1 | 2025 | 277 | 0.180 |
Why?
|
| Proportional Hazards Models | 1 | 2023 | 518 | 0.180 |
Why?
|
| Gastric Emptying | 1 | 2021 | 14 | 0.170 |
Why?
|
| Health Education | 1 | 2024 | 363 | 0.170 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2025 | 989 | 0.160 |
Why?
|
| Papillomavirus Infections | 1 | 2025 | 376 | 0.160 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2022 | 226 | 0.160 |
Why?
|
| Trust | 1 | 2021 | 167 | 0.160 |
Why?
|
| Early Detection of Cancer | 1 | 2024 | 449 | 0.150 |
Why?
|
| Health Services Accessibility | 1 | 2025 | 706 | 0.150 |
Why?
|
| Retrospective Studies | 2 | 2023 | 2544 | 0.150 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 131 | 0.150 |
Why?
|
| HIV Infections | 2 | 2025 | 2586 | 0.150 |
Why?
|
| Diabetes Mellitus | 1 | 2025 | 539 | 0.150 |
Why?
|
| Smoking | 1 | 2025 | 1024 | 0.140 |
Why?
|
| United States | 3 | 2023 | 5205 | 0.140 |
Why?
|
| Neurons | 1 | 2025 | 1263 | 0.140 |
Why?
|
| Female | 8 | 2025 | 24698 | 0.140 |
Why?
|
| Antioxidants | 1 | 2021 | 443 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 760 | 0.110 |
Why?
|
| Male | 5 | 2025 | 23409 | 0.110 |
Why?
|
| Adult | 6 | 2025 | 13872 | 0.100 |
Why?
|
| Neoplasms | 1 | 2024 | 1377 | 0.100 |
Why?
|
| Middle Aged | 5 | 2025 | 12222 | 0.100 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 252 | 0.080 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2025 | 3 | 0.060 |
Why?
|
| Influenza Vaccines | 1 | 2025 | 58 | 0.060 |
Why?
|
| Prenatal Care | 1 | 2025 | 93 | 0.060 |
Why?
|
| Young Adult | 2 | 2025 | 5080 | 0.050 |
Why?
|
| Adolescent | 2 | 2025 | 6081 | 0.050 |
Why?
|
| Intention | 1 | 2024 | 108 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2024 | 259 | 0.050 |
Why?
|
| Self Efficacy | 1 | 2024 | 215 | 0.050 |
Why?
|
| Naloxone | 1 | 2023 | 56 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2024 | 359 | 0.050 |
Why?
|
| Mouth | 1 | 2023 | 54 | 0.050 |
Why?
|
| Rural Population | 1 | 2025 | 373 | 0.040 |
Why?
|
| Sex Factors | 1 | 2025 | 1028 | 0.040 |
Why?
|
| Mitochondria | 1 | 2025 | 523 | 0.040 |
Why?
|
| Pyloric Antrum | 1 | 2021 | 6 | 0.040 |
Why?
|
| Self Care | 1 | 2022 | 175 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 375 | 0.040 |
Why?
|
| Acrolein | 1 | 2021 | 17 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2021 | 57 | 0.040 |
Why?
|
| Community-Based Participatory Research | 1 | 2024 | 352 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2022 | 389 | 0.040 |
Why?
|
| Genotype | 1 | 2023 | 800 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2023 | 380 | 0.040 |
Why?
|
| Pregnancy | 1 | 2025 | 1772 | 0.040 |
Why?
|
| Weight Gain | 1 | 2021 | 139 | 0.040 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2021 | 92 | 0.040 |
Why?
|
| Curcumin | 1 | 2021 | 118 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2023 | 1604 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 1596 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2021 | 408 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2021 | 386 | 0.030 |
Why?
|
| Gene Expression | 1 | 2021 | 701 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2021 | 1035 | 0.030 |
Why?
|
| Animals | 2 | 2025 | 16992 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2021 | 1003 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3156 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2021 | 2157 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 8214 | 0.020 |
Why?
|
| Mice | 1 | 2021 | 6644 | 0.020 |
Why?
|